title: End points for cardiovascular drug trials in pediatric patients.
authors.affiliation: University of Minnesota, Minneapolis 55455, USA. sinai@umn.edu
authors.forename: A R
authors.initials: AR
authors.lastname: Sinaiko
authors.forename: R M
authors.initials: RM
authors.lastname: Lauer
authors.forename: S P
authors.initials: SP
authors.lastname: Sanders
mesh_terms: D000208:Acute Disease; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002648:Child; D002669:Child Welfare; D002908:Chronic Disease; D002986:Clinical Trials as Topic / Q000592:standards*; D015507:Drugs, Investigational / Q000009:adverse effects*; D023381:Endpoint Determination; D006330:Heart Defects, Congenital / Q000188:drug therapy; D006801:Humans
chemical_list: D015507:Drugs, Investigational